UBS Group’s Summit Healthcare Acquisition Corp. Units SMIHU Stock Holding History

UBS Group’s Portfolio SMIHU Stock Details SMIHU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-961	Closed	-$9.72K	–	11292
2022 Q4	$9.72K	Hold	961	–	–	﹤0.01%	8617
2022 Q3	$9K	Buy	961 +300	+45%	+$2.94K	﹤0.01%	8657
2022 Q2	$6K	Sell	661 -10	-1%	-$97	﹤0.01%	8796
2022 Q1	$7K	Sell	671 -281	-30%	-$2.78K	﹤0.01%	8904
2021 Q4	$9K	Sell	952 -100	-10%	-$996	﹤0.01%	8973
2021 Q3	$11K	Sell	1,052 -982	-48%	-$9.85K	﹤0.01%	7931
2021 Q2	$20K	Buy	+2,034	New	+$20.3K	﹤0.01%	7363

UBS Group's SMIHU Position: Q1 2023 in Review

UBS Group sold out of Summit Healthcare Acquisition Corp. Units (SMIHU) in Q1 2023, closing a stake of 961 shares — an estimated $9.72K sold.

UBS Group first reported a position in SMIHU in Q2 2021 and held it in 7 quarters. The position peaked at $20K in Q2 2021. 0 funds tracked by Wall St. Rank hold SMIHU as of Q1 2023.

UBS Group reported no remaining Summit Healthcare Acquisition Corp. Units position as of Q1 2023 after selling out during the quarter.
UBS Group sold 961 Summit Healthcare Acquisition Corp. Units shares in Q1 2023, an estimated $9.72K.
UBS Group first reported a position in Summit Healthcare Acquisition Corp. Units in Q2 2021 and held it in 7 quarters.
UBS Group's Summit Healthcare Acquisition Corp. Units position peaked at $20K in Q2 2021.
0 funds tracked by Wall St. Rank held Summit Healthcare Acquisition Corp. Units as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.